These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 9130097)

  • 21. Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions.
    Tolbert D; Bekersky I; Chu HM; Ette EI
    J Clin Pharmacol; 2016 Mar; 56(3):365-74. PubMed ID: 26224203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between cannabidiol and commonly used antiepileptic drugs.
    Gaston TE; Bebin EM; Cutter GR; Liu Y; Szaflarski JP;
    Epilepsia; 2017 Sep; 58(9):1586-1592. PubMed ID: 28782097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture.
    Nakamura F; Suzuki S; Nishimura S; Yagi K; Seino M
    Epilepsia; 1996 Aug; 37(8):728-35. PubMed ID: 8764810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbamazepine intoxication with negative myoclonus after the addition of clobazam.
    Genton P; Nguyen VH; Mesdjian E
    Epilepsia; 1998 Oct; 39(10):1115-8. PubMed ID: 9776334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Drug Interactions on Clobazam and N-Desmethylclobazam Concentrations in Pediatric Patients With Epilepsy.
    Russell GR; Phelps SJ; Shelton CM; Wheless JW
    Ther Drug Monit; 2018 Aug; 40(4):452-462. PubMed ID: 29746397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and cerebrospinal fluid concentration of clobazam and N-desmethylclobazam.
    Laux G; Koeppen D
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):355-9. PubMed ID: 6147313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome.
    Johannessen Landmark C; Heger K; Lund C; Burns ML; Bjørnvold M; Sætre E; Johannessen SI
    Ther Drug Monit; 2020 Oct; 42(5):744-753. PubMed ID: 32558674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1980 Sep; 20(3):161-78. PubMed ID: 6107238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic drug monitoring of clobazam].
    Bentué-Ferrer D; Tribut O; Verdier MC; Debruyne D;
    Therapie; 2010; 65(3):225-31. PubMed ID: 20699075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clobazam for intractable pediatric epilepsy.
    Sheth RD; Ronen GM; Goulden KJ; Penney S; Bodensteiner JB
    J Child Neurol; 1995 May; 10(3):205-8. PubMed ID: 7642889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?
    Haigh JR; Pullar T; Gent JP; Dailley C; Feely M
    Br J Clin Pharmacol; 1987 Feb; 23(2):213-8. PubMed ID: 3828198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
    Sirmagul B; Atli O; Ilgin S
    Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.
    Sobaniec W
    Mater Med Pol; 1992; 24(2):115-9. PubMed ID: 1307765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam.
    Robertson MM
    Epilepsia; 1986; 27 Suppl 1():S27-41. PubMed ID: 3527689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of clobazam in the treatment of refractory epilepsy in children].
    Dávila-Gutiérrez G; Mondragón-Pineda A; Alcalá-Negrete H
    Bol Med Hosp Infant Mex; 1990 Oct; 47(10):694-7. PubMed ID: 2278646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy.
    Pullar T; Haigh JR; Peaker S; Feely MP
    Br J Clin Pharmacol; 1987 Dec; 24(6):793-7. PubMed ID: 3440099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability.
    Burns ML; Baftiu A; Opdal MS; Johannessen SI; Landmark CJ
    Ther Drug Monit; 2016 Jun; 38(3):350-7. PubMed ID: 26751267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monotherapy with clobazam in epilepsies in children].
    Dulac O; Figueroa D; Rey E; Arthuis M
    Presse Med; 1983 Apr; 12(17):1067-9. PubMed ID: 6221272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.